Featured Research

from universities, journals, and other organizations

Method curbs growth of crystals that form kidney stones

Date:
October 14, 2010
Source:
New York University
Summary:
Researchers have developed a method for curbing the growth of crystals that form cystine kidney stones. Their findings may offer a pathway to a new method for the prevention of kidney stones.

Researchers have developed a method for curbing the growth of crystals that form cystine kidney stones. Their findings, which appear in the latest issue of the journal Science, may offer a pathway to a new method for the prevention of kidney stones.

Related Articles


The study was conducted by researchers at New York University's Department of Chemistry and its Molecular Design Institute, NYU School of Medicine, and the Medical College of Wisconsin.

Kidney stones comprised of L-cystine affect at least 20,000 individuals in the United States. This number is substantially smaller than the 10 percent of Americans afflicted by calcium oxalate monohydrate (COM) stones. But L-cystine stones are larger, recur more frequently, and are more likely to cause chronic kidney disease. Current treatments for this disease are somewhat effective, but often lead to adverse side effects.

The formation of L-cystine stones is a consequence of excessive levels of L-cystine in the urine. L-cystine forms into crystals, which aggregate into stones, reaching up to a centimeter in diameter.

Current treatments for L-cystine stone prevention, such as dilution through high fluid intake, can suppress, but may not completely prevent, stone formation. Some medications can react with L-cystine to generate more soluble compounds, but these drugs can cause adverse side effects such as nausea, fever, fatigue, skin allergies, and hypersensitivity.

With the limitations of current treatments in mind, the researchers sought to curb the formation and growth of L-cystine crystals.

Using atomic force microscopy (AFM), which allows for the observation of objects as small as a nanometer, the researchers found that L-cystine crystals grow through the continual attachment of L-cystine molecules to the edges of hexagon-shaped hillocks on the crystal surface. This process results in spiral growth patterns.

Knowing how these crystals grew, the researchers could then select a chemical agent to inhibit this process. Crystal growth can be altered through the use of tailored growth inhibitors. These inhibitors reduce crystallization rates by binding to crystal surfaces in ways that prevent the addition of crystal molecules to the surface, which is necessary for their normal formation.

In the Science study, the researchers used a synthetic agent, L-CDME, which is structurally identical to L-cystine in its center, but is equipped with different molecular "blocking" groups at the ends designed to prevent the attachment of L-cystine molecules to the crystal surface.

Using AFM to observe crystal growth and the effect of this designer inhibitor, the NYU investigators found that L-CDME blocked the growth of the L-cystine crystals by binding to L-cystine molecules protruding from the edges of the hexagon-shaped hillocks. Consequently, the blocking groups obstructed the approach of additional L-cystine molecules to those edges. The researchers found similar success with the introduction of another synthetic agent, L-CME. Their results were confirmed by parallel measurements of crystal yields under the same conditions.

"This may lead to a new approach to preventing cystine stones simply by stopping crystallization," explained Michael Ward, the study's corresponding author and chair of NYU's Department of Chemistry. "Moreover, these findings are an example of the significant advances that can be achieved through collaborations between researchers in physical sciences and in medicine."

The study's other co-authors include: Jeffrey D. Rimer, a former postdoctoral fellow at NYU's Department of Chemistry and now an assistant professor at the University of Houston; Zhihua An, a postdoctoral fellow at NYU's Department of Chemistry; Zina Zhu, a doctoral student at NYU's Department of Chemistry; Michael Lee, a former NYU chemistry undergraduate now enrolled in the NYU Medical School; David Goldfarb, a professor at NYU School of Medicine; and Jeffrey A. Wesson, an associate professor at the Medical College of Wisconsin.


Story Source:

The above story is based on materials provided by New York University. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. D. Rimer, Z. An, Z. Zhu, M. H. Lee, D. S. Goldfarb, J. A. Wesson, M. D. Ward. Crystal Growth Inhibitors for the Prevention of L-Cystine Kidney Stones Through Molecular Design. Science, 2010; 330 (6002): 337 DOI: 10.1126/science.1191968

Cite This Page:

New York University. "Method curbs growth of crystals that form kidney stones." ScienceDaily. ScienceDaily, 14 October 2010. <www.sciencedaily.com/releases/2010/10/101014144227.htm>.
New York University. (2010, October 14). Method curbs growth of crystals that form kidney stones. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2010/10/101014144227.htm
New York University. "Method curbs growth of crystals that form kidney stones." ScienceDaily. www.sciencedaily.com/releases/2010/10/101014144227.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins